Independent Solutions Wealth Management LLC Buys New Holdings in UnitedHealth Group Incorporated $UNH

by · The Cerbat Gem

Independent Solutions Wealth Management LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 4,678 shares of the healthcare conglomerate’s stock, valued at approximately $1,615,000.

Several other institutional investors and hedge funds have also made changes to their positions in UNH. Benjamin Edwards Inc. raised its position in shares of UnitedHealth Group by 20.5% during the 3rd quarter. Benjamin Edwards Inc. now owns 52,604 shares of the healthcare conglomerate’s stock worth $18,171,000 after acquiring an additional 8,946 shares in the last quarter. TCV Trust & Wealth Management Inc. lifted its position in shares of UnitedHealth Group by 0.5% during the 3rd quarter. TCV Trust & Wealth Management Inc. now owns 41,539 shares of the healthcare conglomerate’s stock worth $14,343,000 after buying an additional 191 shares during the last quarter. Howard Financial Services LTD. purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at $212,000. Spire Wealth Management boosted its stake in UnitedHealth Group by 4.9% in the third quarter. Spire Wealth Management now owns 17,401 shares of the healthcare conglomerate’s stock valued at $6,009,000 after acquiring an additional 807 shares in the last quarter. Finally, Realta Investment Advisors increased its position in shares of UnitedHealth Group by 33.7% during the third quarter. Realta Investment Advisors now owns 1,974 shares of the healthcare conglomerate’s stock worth $682,000 after purchasing an additional 498 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 2.0%

NYSE:UNH opened at $341.96 on Thursday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.82 and a current ratio of 0.82. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The stock has a market capitalization of $309.76 billion, a price-to-earnings ratio of 17.85, a PEG ratio of 2.11 and a beta of 0.42. The stock has a fifty day moving average price of $329.42 and a two-hundred day moving average price of $320.61.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. The company had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same period last year, the firm earned $7.15 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Monday, December 8th were given a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s payout ratio is currently 46.14%.

Wall Street Analysts Forecast Growth

UNH has been the subject of several research analyst reports. Royal Bank Of Canada increased their price objective on UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. Deutsche Bank Aktiengesellschaft cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target for the company. in a research note on Wednesday, October 29th. Morgan Stanley increased their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a research note on Friday, September 12th. TD Cowen increased their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the stock a “hold” rating in a research report on Thursday, October 30th. Finally, Wells Fargo & Company increased their price target on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $385.75.

Get Our Latest Analysis on UnitedHealth Group

About UnitedHealth Group

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).